CDC Identifies Contamination in More Medical Products From New England Compounding Center
The CDC has identified additional microbial contamination in unopened vials of betamethasone, cardioplegia and triamcinolone solutions that were distributed and recalled from NECC.
Clinicians should continue to report infections related to NECC products to FDA's MedWatch and state health departments.
Related Articles on ASC Medical Supplies:
Access MediQuip Names Patrick McCarthy Chief Network Development Officer
Volcano Corp. to Acquire Crux Biomedical
FDA Enters Partnership to Help Increase Access to New Medical Devices
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Texas & Florida lack funding to launch substantial Zika prevention awareness among pregnant women: 4 insights
- Global healthcare payer BPO market to hit $34.2B: 6 things to know
- CDC awards $226M to 5 academic centers for patient safety efforts: 5 notes
- Texas Fertility Center opens ASC to bring fertility services to Austin residents: 5 points
- Global ophthalmology devices market to reach $18.28B: 5 takeaways